Table 4.
Variable | Overall Survival | ||
---|---|---|---|
No. (%) | Hazard Ratio (95% CI) | p-value | |
Age | <0.012 | ||
<65 years | 167 (35) | Ref. | |
≥65 years | 312 (65) | 1.89 (1.52 – 2.36) | |
Gender | 0.022 | ||
Female | 312 (65) | Ref. | |
Male | 167 (35) | 1.31 (1.05 – 1.64) | |
Clinical subtype | |||
Secondary AS1 | 259 (54) | Ref. | |
Primary AS | 169 (35) | 1.51 (1.20 – 1.89) | <0.012 |
Unknown | 51 (11) | 1.04 (0.71 – 1.52) | 0.84 |
Tumor depth | |||
Superficial | 134 (28) | Ref. | |
Deep | 25 (5) | 1.93 (1.18 – 3.16) | <0.012 |
Unknown | 320 (67) | 1.15 (0.89 – 1.48) | 0.29 |
Distant metastases | |||
No | 324 (68) | Ref. | |
Yes | 79 (17) | 2.09 (1.54 – 2.85) | <0.012 |
Unknown | 76 (16) | 1.72 (1.31 – 2.25) | <0.012 |
Surgery | <0.012 | ||
Yes | 306 (64) | Ref. | |
No | 173 (36) | 2.52 (1.93 – 3.29) | |
Radiation therapy | 0.10 | ||
(Neo)adjuvant | 54 (11) | Ref. | |
Primary | 41 (9) | 0.91 (0.55 – 1.51) | |
No | 384 (80) | 1.26 (0.89 – 1.78) |
CI = confidence interval, 1 RT, UV and Stewart Treves AS, 2 p < 0.05.